2 active not recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 2, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Refractory Malignant Glioma: new trials by email Literature Review of Refractory Malignant Glioma trials Research Report on Refractory Malignant Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors LUTATHERA® (Lutetium Lu 177 dotatate) - High Grade Glioma, Meningioma | Phase 1 / Phase 2 | Recruiting | Nationwide Children's Hospital | 65 | 2022-11-21 | 2026-07-20 |
| Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors Biospecimen Collection, Magnetic Resonance Imaging, Savolitinib - Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Malignant Glioma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 41 | 2018-11-27 | 2026-07-30 |
| Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma Arm 1: IL13Ra2-specific CAR Tcm cells, Arm 2: IL13Ra2-specific CAR Tcm cells, Arm 3: IL13Ra2-specific CAR Tcm cells - Recurrent Glioblastoma, Recurrent Malignant Glioma | Phase 1 | Active not recruiting | City of Hope Medical Center | 65 | 2015-06-03 | 2026-11-04 |
Glioma (3) · Central Nervous System Neoplasms (2) · Diffuse Intrinsic Pontine Glioma (2) · Medulloblastoma (2) · Ependymoma (1) · Glioblastoma (1) · Meningioma (1) · Neoplasms, Germ Cell and Embryonal (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Brain Diseases (2) · Brain Neoplasms (2) · Brain Stem Neoplasms (2) · Central Nervous System Diseases (2) · Infratentorial Neoplasms (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2)
Magnetic Resonance Spectroscopy (2) · 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine (1) · Phantoms, Imaging (1) · Specimen Handling (1) · X-Rays (1) · lutetium Lu 177 dotatate (1)
City of Hope Medical Center (1) · National Cancer Institute (NCI) (1) · Nationwide Children's Hospital (1)
United States (3) · Canada (1)
Behnam Badie (1) · Margot Lazow, MD (1) · Ralph Salloum (1)
P30CA033572 (1), UM1CA081457 (1)